Medherant

United Kingdom
Coventry, England, United Kingdom
+442476323060 ★

Company profile

Medherant company profile

Medherant was founded by Professor David Haddleton and the University of Warwick to develop and commercialise novel transdermal drug delivery platforms. Current patch technologies have limited drug loading capabilities, making them unviable for use with many pharmaceutical products that could benefit from transdermal delivery. Creams and gels on the other hand suffer from a lack of dose control that is critical for many drugs.

Business identity

Contact email
[email protected]
Phone number
+442476323060
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2015-01-01

Headquarters

Headquarters
Coventry, England, United Kingdom
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
5
Total equity funding
$11.2M
Last funding
Series Unknown / $3.6M / 2023-04-03
Last equity funding
Series Unknown / $3.6M
Investors
2
Lead investors
2
Founders
1
Articles
3

Founders and investors

Founders

David Haddleton

Lead investors

Innovate UKMercia Asset Management

Investors

Innovate UKMercia Asset Management

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.